Iox Therapeutics Limited
09430782
Some Concerns
- Negative net worth (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 16/04/2025
Due 30/04/2026
Industry
Officers
Persons with Significant Control
Former PSCs
Salvarx Limited
Ceased 08/01/2019
Portage Biotech Inc
Ceased 21/10/2021
CompanyRankvs 2083+ SIC 72110 peers31
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
its ability to provide ongoing support is not guaranteed. These factors indicate the existence of a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern. Nevertheless, the Directors believe that the going concern basis of preparation remains appropriate, based on the funding received to date, the parent company’s stated intention to provi
Key FinancialsYear ending 31/12/2024
Net Worth
-£10.6M
Balance sheet strength
Cash
£45k
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
£132k
Current Liabilities
£10.7M
Debtors
£87k
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 0.01 |
Derived from filed accounts. Not audited figures.